GSK says antibody drug sotrovimab works against Omicron mutations
GlaxoSmithKline and Vir Biotechnology announced an update to bioRxiv a preprint server, with preclinical data demonstrating that sotrovimab, an investigational monoclonal antibody, retains activity ag...